Overview


According to FutureWise analysis the market for Blood Collection Devices is expected to reach US$ 11.05 billion by 2031 at a CAGR of 7.00%.

The process of collecting whole blood from blood banks and processing it to separate its constituent components is known as blood collection. Blood collection is one of the most popular diagnostic tools, allowing healthcare practitioners to manage, diagnose, and prescribe treatment for a variety of conditions with ease. Blood tests can help manage, diagnose, and treat a number of essential and dangerous disorders, including diabetes, cardiovascular disease, and a variety of malignancies. Blood donation, on the other hand, may be carried out efficiently with the help of technologically improved blood collection instruments. In the contemporary market, more technologically improved blood collecting equipment have been introduced. As a result, for a variety of healthcare activities such as blood collection and blood testing, the availability and presence of advanced blood collection instruments is crucial. Due to factors such as an ageing population, an increase in the frequency of chronic diseases, technological improvements in blood collection equipment, and increased awareness about blood testing, the blood collection devices market is likely to grow at a rapid pace during the forecast period. However, a lack of adequate testing in developing nations, as well as some product recalls of blood collection devices, are two main concerns that are anticipated to limit the global market's growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Blood Collection Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Blood Collection Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Becton, Dickinson and Company
  • Haematonics
  • Terumo BCT
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Nipro Medical Corporation
  • Greiner Holding
  • Quest Diagnostics
  • SARSTEDT AGCo.
  • Macopharma
  • Smiths Medical
  • Cardinal Health
  • Retractable Technologies
  • Liuyang Sanli Medical Technology Development
  • F.L. Medical S.R.L.
  • AB Medical
  • APTCA SPA
  • Jiangsu Micsafe Medical Technology CO., LTD.
  • Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Þ
  • Ajosha Bio Teknik Pvt. Ltd.
  • Preq Systems
  • CML Biotech
  • Lmb Technologie GmbH
  • Mitra Industries Private Limited
  • Neomedic Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Blood Collection tubes
    • Plasma/whole-blood tubes
      • EDTA Tubes
      • Heparin Tubes
      • Coagulation Tubes
      • Glucose Tubes
      • ESR Tubes
    • Serum Tubes
  • System Type
    • Vacuum Tubes
    • Non-vacuum Tubes
  • Needles and Syringes
  • Blood Bags
  • Blood Collection Systems/Monitors
  • Lancets

By Application

  • Diagnostics
  • Therapeutics

By Method

  • Manual Blood Collection
  • Automated Blood Collection

By End User

  • Hospitals, Ambulatory Surgical Centers, and Nursing Homes
  • Diagnostic and Pathology Laboratories
  • Blood Banks
  • Other End Users

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Blood Collection Devices Market By Product, By Application, By Method, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Blood Collection Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Blood Collection Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Blood Collection Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Blood Collection Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Collection tubes
         1.1. Plasma/whole-blood tubes
          1.1.1. EDTA Tubes
          1.1.2. Heparin Tubes
          1.1.3. Coagulation Tubes
          1.1.4. Glucose Tubes
          1.1.5. ESR Tubes
         1.2. Serum Tubes
        2. System Type
         2.1. Vacuum Tubes
         2.2. Non-vacuum Tubes
        3. Needles and Syringes
        4. Blood Bags
        5. Blood Collection Systems/Monitors
        6. Lancets

  • 8.   Blood Collection Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostics
        2. Therapeutics

  • 9.   Blood Collection Devices Market, By Method Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Manual Blood Collection
        2. Automated Blood Collection

  • 10.   Blood Collection Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals, Ambulatory Surgical Centers, and Nursing Homes
        2. Diagnostic and Pathology Laboratories
        3. Blood Banks
        4. Other End Users

  • 11.   North America Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Becton, Dickinson and Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Haematonics
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Terumo BCT
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Fresenius Kabi AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Grifols, S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Nipro Medical Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Greiner Holding
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Quest Diagnostics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. SARSTEDT AGCo.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Macopharma
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Smiths Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Cardinal Health
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Retractable Technologies
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Liuyang Sanli Medical Technology Development
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.F.L. Medical S.R.L.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.AB Medical
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
           17.APTCA SPA
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
           18.Jiangsu Micsafe Medical Technology CO., LTD.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Þ
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
           20.Ajosha Bio Teknik Pvt. Ltd.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
           21.Preq Systems
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22.CML Biotech
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23.Lmb Technologie GmbH
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24.Mitra Industries Private Limited
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25.Neomedic Limited
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients